CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+13.82%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.5B
AUM Growth
+$14.5B
(+2.7%)
Cap. Flow
+$373M
Cap. Flow
% of AUM
2.58%
Top 10 Holdings %
Top 10 Hldgs %
26.25%
Holding
738
New
61
Increased
262
Reduced
284
Closed
31
Top Buys
| 1 |
Visa
V
|
$77.8M |
| 2 |
Gilead Sciences
GILD
|
$59.3M |
| 3 |
Microsoft
MSFT
|
$46.6M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$40.2M |
| 5 |
Nu Holdings
NU
|
$39.1M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$112M |
| 2 |
Royal Bank of Canada
RY
|
$51.1M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$42.8M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$38.9M |
| 5 |
Merck
MRK
|
$33.3M |
Sector Composition
| 1 | Technology | 30.32% |
| 2 | Healthcare | 28.88% |
| 3 | Consumer Discretionary | 8.63% |
| 4 | Financials | 8.52% |
| 5 | Industrials | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Syndax Pharmaceuticals
SNDX
$1.39B
| $22.1M | 0.15% |
1,021,032
+781,022
| +325% | +$16.9M |
|
152
Valero Energy
VLO
$48.3B
| $21.2M | 0.15% |
162,754
-43,278
| -21% | -$5.63M |
|
153
Sherwin-Williams
SHW
$90.5B
| $21.1M | 0.15% |
67,648
-1,546
| -2% | -$482K |
|
154
Morgan Stanley
MS
$237B
| $21.1M | 0.15% |
226,252
-273,560
| -55% | -$25.5M |
|
155
Owens Corning
OC
$12.4B
| $20.8M | 0.14% |
140,266
-54,407
| -28% | -$8.07M |
|
156
Exact Sciences
EXAS
$9.33B
| $20.6M | 0.14% |
278,670
+131,582
| +89% | +$9.73M |
|
157
Nuvalent
NUVL
$5.74B
| $20.6M | 0.14% |
280,009
-70,008
| -20% | -$5.15M |
|
158
Apellis Pharmaceuticals
APLS
$3.51B
| $20.2M | 0.14% |
337,507
+11,000
| +3% | +$658K |
|
159
Arvinas
ARVN
$580M
| $20.1M | 0.14% |
487,555
+40,004
| +9% | +$1.65M |
|
160
Fair Isaac
FICO
$36.5B
| $20M | 0.14% |
17,191
-5,612
| -25% | -$6.53M |
|
161
Electronic Arts
EA
$42B
| $19.5M | 0.13% |
142,528
+32,831
| +30% | +$4.49M |
|
162
Idexx Laboratories
IDXX
$50.7B
| $19.2M | 0.13% |
34,636
-599
| -2% | -$332K |
|
163
Jabil
JBL
$21.8B
| $19.2M | 0.13% |
150,823
-22,367
| -13% | -$2.85M |
|
164
Colgate-Palmolive
CL
$67.7B
| $18.7M | 0.13% |
233,977
-216,005
| -48% | -$17.2M |
|
165
Netflix
NFLX
$521B
| $18.5M | 0.13% |
37,954
+3,417
| +10% | +$1.66M |
|
166
Exelon
EXC
$43.8B
| $18.4M | 0.13% |
512,636
+386,987
| +308% | +$13.9M |
|
167
Welltower
WELL
$112B
| $18.3M | 0.13% |
202,559
+157,845
| +353% | +$14.2M |
|
|
168
Royal Bank of Canada
RY
$205B
| $18.2M | 0.13% |
178,751
-502,411
| -74% | -$51.1M |
|
169
Zebra Technologies
ZBRA
$15.5B
| $18.1M | 0.13% |
66,317
-2,170
| -3% | -$593K |
|
|
KRTX
170
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $18.1M | 0.13% |
57,201
-4,000
| -7% | -$1.27M |
|
171
eBay
EBAY
$41.2B
| $18M | 0.12% |
412,349
-87,251
| -17% | -$3.81M |
|
172
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$3.46B
| $17.8M | 0.12% |
647,075
+87,970
| +16% | +$2.43M |
|
173
TopBuild
BLD
$11.8B
| $17.8M | 0.12% |
47,451
-13,005
| -22% | -$4.87M |
|
174
Sarepta Therapeutics
SRPT
$1.98B
| $17.6M | 0.12% |
182,445
+46,736
| +34% | +$4.51M |
|
175
Wabtec
WAB
$32.7B
| $17.5M | 0.12% |
137,666
-8,780
| -6% | -$1.11M |
|